Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM7452Antiepileptics or antiparkinsonism drugs
XM9G63Antiparkinson drugs
XM5Y20Dopaminergic agents
XM7SN1Dopa and dopa derivatives

XM6R13 category

Etilevodopa and Decarboxylase inhibitor

Also indexed as

Etilevodopa and Decarboxylase inhibitor

Nearby in Dopa and dopa derivatives

XM2WU7Levodopa
XM7ZB9Levodopa and decarboxylase inhibitor
XM3PK3Levodopa, Decarboxylase inhibitor and COMT inhibitor
XM1JZ7Melevodopa
XM0D22Melevodopa and Decarboxylase inhibitor

PreviousXM0D22 — Melevodopa and Decarboxylase inhibitor

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
XM0QJ8Neuroprotective agents, not elsewhere classified
XM7BA9Analgesics, antipyretics or anti-inflammatory drugs
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
XM4G94Antidepressants
XM98Y0Cannabinoids or hallucinogens
XM9NV2Opioids
14 more
XM63D6Antiepileptics
XM9G63Antiparkinson drugs
XM5Y20Dopaminergic agents
XM1Z60Carbidopa
XM7SN1Dopa and dopa derivatives
Dopamine agonists
XM9GG4Monoamine oxidase B inhibitors
XM2H09Amantadine
XM0BA4Tolcapone
XM07G6Entacapone
XM0K96Budipine
XM6TZ5Opicapone
XM2WU7Levodopa
XM7ZB9Levodopa and decarboxylase inhibitor
XM3PK3Levodopa, Decarboxylase inhibitor and COMT inhibitor
XM1JZ7Melevodopa
XM0D22Melevodopa and Decarboxylase inhibitor
XM6R13Etilevodopa and Decarboxylase inhibitor

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact